Home / Compounds / Phenibut / Nevada

Is Phenibut Legal in Nevada? (2026)

Legal

As of November 12, 2026, Phenibut is legal to sell at retail in Nevada. Nevada: phenibut not named in schedules located. Controlling source: NAC 453.510 Schedule I.

Verified November 12, 2026 (hash check) · confidence: confirmed

Is Phenibut Legal? Every state and federal law

QuietNo pending legislation, deadlines or enforcement actions on file for Phenibut in Nevada.
Rule type
permanent
Tier
Unscheduled

What the record says

Nevada administrative schedules and 2026 Schedule I updates reviewed do not name phenibut. NRS 453.043 requires substantially similar structure to a Schedule I or II substance plus effect or intent; no supported controlled-substance structural anchor was identified. An advisory working group proposed age and labeling rules; a recommendation is not enacted law.

Controlling language, verbatim

Schedule I consists of the drugs and other substances listed in this section by whatever official, common, usual, chemical or trade name designated.

Source of excerpt

Citations

  1. NAC 453.510 Schedule I (Official publisher, 2026-11-01) PRIMARYOFFICIAL
  2. NRS 453.043 and 453.219 (Official publisher, 2026-11-01) PRIMARYOFFICIAL
  3. Nevada R038-26 filed July 1, 2026 (Official publisher, 2026-11-01) PRIMARYOFFICIAL
  4. Nevada R107-25 filed April 29, 2026 (Official publisher, 2026-11-01) PRIMARYOFFICIAL
  5. Nevada R204-24 filed February 27, 2026 (Official publisher, 2026-11-01) PRIMARYOFFICIAL
  6. Nevada AG 2025-2026 SURG recommendations (Official publisher, 2026-11-01) PRIMARYOFFICIAL

Where Phenibut stands across the country

LegalRestrictedGray areaIllegalNot yet verified

Among Nevada’s 5 neighbors, Utah is illegal; California is gray area; Arizona, Idaho and Oregon are legal.

Open the interactive map · Every compound in Nevada · Where Phenibut is banned · Embed this map

Federal posture

Not federally scheduled. Phenibut is not federally scheduled; FDA restricts dietary supplement marketing Federal detail

Verbatim law on file for Nevada

7 instruments on file for this compound’s framework in Nevada; 6 of 6 citations above are official sources. Each text carries its source and a fingerprint that changes when the law does.

NAC 453.510(2), R054-24 effective 2024-06-20 · Controlled substances scheduleOFFICIAL
Instrument
Controlled substances schedule
Source
https://www.leg.state.nv.us/NAC/NAC-453.html
Retrieved
2026-11-01
Fingerprint
6e88d08fcdc4ba19
2. Unless specifically excepted or unless listed in another schedule, any of the following opiates, including, without limitation, their isomers, esters, ethers, salts and salts of isomers, esters and ethers, whenever the existence of such isomers, esters, ethers and salts is possible within the specific chemical designation:

Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);

Acetylmethadol;

Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) (some trade or other names: acryloylfentanyl);

Allylprodine;

Alphacetylmethadol (except levo-alphacetylmethadol, commonly referred to as levo-alpha-acetylmethadol, levomethadyl acetate or “LAAM”);

Alphameprodine;

Alphamethadol;

Alpha'-methyl butyryl fentanyl (2-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide);

Alphamethylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine);

Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);

Benzethidine;

Betacetylmethadol;

Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide);

Beta-hydroxy-3-methylfentanyl (other name: N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide);

Beta-hydroxythiofentanyl (trade or other names: N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide; N-[1-[2-hydroxy-2-(2-thienyl)ethyl]-4-piperidinyl]-N-phenylpropanamide);

Betameprodine;

Betamethadol;

Betaprodine;

Butyryl fentanyl (trade or other names: N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide; N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide);

Clonitazene;

Cyclopentyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide);

Cyclopropyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide);

Dextromoramide;

Diampromide;

Diethylthiambutene;

Difenoxin;

Dimenoxadol;

Dimepheptanol;

2′,5′-dimethoxyfentanyl (N-(1-(2,5-dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide);

Dimethylthiambutene;

Dioxaphetyl butyrate;

Dipipanone;

Ethylmethylthiambutene;

Etonitazene;

Etoxeridine;

Eutylone (bk-EBDB, 1-(1,3-Benzodioxol-5-yl)-2-(ethylamino)butan-1-one, b-keto-ethylbenzodioxolylbutanamine);

Fentanyl carbamate (Ethyl-(1-phenethylpiperidin-4-yl)(phenyl)carbamate);

Fluoro furanyl fentanyl;

Fluoroacryl fentanyl;

Fluorobutyryl fentanyl;

Fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-piperidinyl]propanamide);

Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide);

Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide);

3-Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-3-carboxamide);

Furethidine;

Hydroxypethidine;

Isobutyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide);

Isotonitazene;

Isovaleryl fentanyl (3-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide);

Ketobemidone;

Levomoramide;

Levophenacylmorphan;

Meta-fluorofentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide);

Meta-fluoroisobutyryl fentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl) isobutyramide);

Methoxyacetyl fentanyl;

Methyl acetyl fentanyl;

Methyl methoxyacetyl fentanyl (some trade or other names: 2-methoxy-N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide (ortho-methyl methoxyacetylfentanyl; 2-methyl methoxyacetyl fentanyl));

Methylfentanyl;

Methylthiofentanyl;

Morpheridine;

MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);

Noracymethadol;

Norlevorphanol;

Normethadone;

N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)propionamide (2'-fluoro ortho-fluorofentanyl; 2'-fluro 2'-fluorofentanyl);

Norpipanone;

Ocfentanil (N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide;

Ortho-fluorofuranyl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide);

Para-chloroisobutyryl fentanyl (N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide);

Para-fluorobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide);

Para-methoxybutyryl fentanyl (N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide);

Para-methoxyfuranyl fentanyl (N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide);

Para-methylcyclopropyl fentanyl (N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)cyclopropanecarboxamide);

PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine);

Phenadoxone;

Phenampromide;

Phenomorphan;

Phenoperidine;

Phenyl fentanyl (some trade or other names: benzoyl fentanyl);

Phenylpropanoyl fentanyl;

Piritramide;

Proheptazine;

Properidine;

Propiram;

Racemoramide;

Tetrahydrofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide);

Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-propanamide);

Thiofuranyl fentanyl (some trade or other names: thiophene fentanyl);

Tianeptine;

Tilidine;

Trimeperidine; or

Valeryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide).
Nev. Admin. Code 453.510(4) · Schedule I (hallucinogenic substances)OFFICIAL
Instrument
Schedule I (hallucinogenic substances)
Source
https://www.leg.state.nv.us/NAC/NAC-453.html
Retrieved
2026-11-06
Fingerprint
8a5d834bd75a91f6
4.  Unless specifically excepted or unless
listed in another schedule, any material, compound, mixture or preparation
which contains any quantity of the following hallucinogenic substances, including,
without limitation, their salts, isomers and salts of isomers, whenever the
existence of such salts, isomers and salts of isomers is possible within the
specific chemical designation:

 

ADB-4en-PINACA
(some trade or other names: N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(pent-4-en-1-yl)-1H-indazole-3-carboxamide);

 

ADB-BUTINACA (some
trade or other names:
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-butyl-1H-indazole-3-carboxamide);

 

Adinazolam (some
trade or other names: 8-chloro-1-((dimethylamino)methyl)-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine;
adinazolamum; Deracyn);

 

Alpha-ethyltryptamine
(some trade or other names: ET, Trip);

 

Alpha-methyltryptamine
(some trade or other names: AMT);

 

Alpha-PiHP (some
trade or other names: 4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one);

 

Bromazolam (some
trade or other names:
8-bromo-1-methyl-6-phenyl-4H[1,2,4]triazolo[4,3-a][1,4]benzodiazepine;
XLI-268);

 

1,4-Butanediol
(some trade or other names: 1,4-butyleneglycol, dihydroxybutane, tetramethylene
glycol, butane 1,4-diol, SomatoPro, Soma Solutions, Zen);

 

4-bromo-2,5-dimethoxyamphetamine
(some trade or other names: 4-bromo-2,5-dimethoxy-alpha-methylphenethylamine;
4-bromo-2,5-DMA);

 

4-bromo-2,5-dimethoxyphenethylamine
(some trade or other names: Nexus, 2C-B);

 

1-Butyl-3-(1-naphthoyl)indole-7173
(some trade or other names: JWH-073);

 

2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine
(some trade or other names: 2C-C);

 

4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine
(some trade or other names: Etizolam);

 

Clonazolam (some
trade or other names:
6-(2-chlorophenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine;
clonitrazolam);

 

CUMYL-PEGACLONE
(some trade or other names: SGT-151; 5-Pentyl-2-(2-phenylpropan-2-yl)pyrido[4,3-b]indol-1-one;
2,5-dihydro-2-(1-methyl-1-phenylethyl)-5-pentyl-1H-pyrido[4,3-b]indol-1-one);

 

1-cyclohexylethyl-3-(2-methoxyphenylacetyl)indole
(some trade or other names: SR-18; BTM-8; RCS-8);

 

Diclazepam (some
trade or other names: 7-chloro-5-(2-chlorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one;
7-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one;
2'-chlorodiazepam; Chlorodiazepam; Ro 5-3448);

 

2,5-dimethoxyamphetamine
(some trade or other names: 2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA);

 

2,5-dimethoxy-4-ethylamphet-amine
(some trade or other names: DOET);

 

2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine
(some trade or other names: 2C-E);

 

2-(2,5-Dimethoxy-4-methylphenyl)ethanamine
(some trade or other names: 2C-D);

 

2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine
(some trade or other names: 2C-N);

 

2,5-Dimethoxy-N-(2-methoxybenzyl)
phenethylamine (NBOMe) and any derivative thereof (some trade or other names:
2C-X-NBOMe; N-benzylated phenethylamines; N-o-methoxybenzyl analogs; NBOMe;
25H-NBOMe; 25B-NBOMe; 25C-NBOMe; 25D-NBOMe; 25E-NBOMe; 25I-NBOMe; 25N-NBOMe;
25P-NBOMe; 25T2-NBOMe; 25T4-NBOMe; 25T7-NBOMe);

 

2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine
(some trade or other names: 2C-P);

 

2,5-dimethoxy-4-(n)-propylthiophenethylamine
(some trade or other names: 2C-T-7);

 

2-(2,5-Dimethoxyphenyl)ethanamine
(some trade or other names: 2C-H);

 

3-[(2-Dimethylamino)ethyl]-1H-indol-4-yl
acetate (some trade or other names: 4-acetoxy-N,
N-dimethyltryptamine;4-AcO-DMT; psilacetin; O-acetylpsilocin; 4-acetoxy-DMT);

 

5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol-7297
(some trade or other names: CP-47,497);

 

5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol-7298
(some trade or other names: cannabicyclohexanol; CP-47,497 C8 homologue);

 

Ethyl
2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (some
trade or other names: 5F-EDMB-PINACA);

 

4-ethylnaphthalen-1-yl-(1-pentylindol-3-yl)methanone
(some trade or other names: (4-ethyl-1-naphthalenyl)(1-pentyl-1H-indol-3-yl)-methanone;
JWH-210);

 

2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine
(some trade or other names: 2C-T-2);

 

5F-EDMB-PICA (some
trade or other names: 5F-EDMB-2201; Ethyl
2-[[1-(5-fluoropentyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate;
N-[[1-(5-fluoropentyl)-1H-indol-3-yl]carbonyl]-3-methyl-L-valine, ethyl ester);

 

4F-MDMB-BUTICA
(some trade or other names: 4F-MDMB-BICA; Methyl
2-[[1-(4-fluorobutyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate;
N-[[1-(4-fluorobutyl)-1H-indol-3-yl]carbonyl]-3-methyl-L-valine, methyl);

 

Flualprazolam (some
trade or other names:
8-chloro-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine;
8-chloro-6-(2-fluoro-phenyl)-1-methyl-4h-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine;
2'-fluoro alprazolam; ortho-fluoro alprazolam);

 

Flubromazepam (some
trade or other names:
7-bromo-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one;
7-Bromo-5-(2-fluorophenyl)-1H-benzo[e][1,4]diazepin-2(3H)-one;
7-bromo-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one);

 

Flubromazolam (some
trade or other names:
8-bromo-6-(2-fluorophenyl)-1-methyl-4H-(1,2,4)triazolo(4,3-a)(1,4)benzodiazepine);

 

Flunitrazolam (some
trade or other names: 6-(2-fluorophenyl)-1-methyl-8-nitro-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine);

 

(1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone
(some trade or other names: FUB-144);

 

2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylbutanoate
(Some trade or other names: FUB-AMB; MMB-FUBINACA);

 

[1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone
(some trade or other names: THJ-2201; 5-fluoro THJ 018; AM2201 indazole analog;
fluorpentyl JWH-018 indazole);

 

[1-(5-fluoropentyl)-1H-indol-3-yl]-1-naphthalenyl-methanone
(some trade or other names: 1-(5-fluoropentyl)-3-(1-naphthoyl)indole; AM-2201);

 

[1-(5-fluoropentyl)-1H-indol-3-yl]-(2-iodophyenyl)-methanone
(some trade or other names: 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole;
AM-694);

 

(1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone
(some trade or other names: XLR-11);

 

1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide
(some trade or other names: 5F-CUMYL-PINACA; SGT-25);

 

1-(5-fluoropentyl)-N-(tricyclo[3.3.1.13,7]dec-1-yl)-1H-indazole-3-carboxamide
(some trade or other names:
N-((3s,5s,7s)-adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide;
APINACA 5-fluoropentyl analog; 5F-AKB48; 5-Fluoro-AKB48; 5F-APINACA;
5-Fluoro-APINACA;

 

1-(5-fluoropentyl)-8-quinolinyl
ester-1H-indole-3-carboxylic acid (some trade or other names:
1-(5-fluoropentyl)-1H-indole-3-carboxylic acid 8-quinolinyl ester;
5-Fluoro-PB-22; 5F-PB-22);

 

Flutoprazepam (some
trade or other names:
7-chloro-1-(cyclopropylmethyl)-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one);

 

2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine
(some trade or other names: 2C-I);

 

2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine
(some trade or other names: 2C-T-4);

 

1-hexyl-3-(1-naphthoyl)indole
(some trade or other names: JWH-019);

 

MDMB-4en-PINACA
(some trade or other names: Methyl
3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido)butanoate);

 

Meclonazepam (some
trade or other names:
(3S)-5-(2-chlorophenyl)-1,3-dihydro-3-methyl-7-nitro-2H-1,4-benzodiazepin-2-one;
Ro 11-3128);

 

Methoxetamine (some
trade or other names: MXE; 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone);

 

3-MMC (some trade
or other names: 3-methylmethcathinone;
2-(methylamino)-1-(3-methylphenyl)propan-1-one);

 

4-methoxyamphetamine
(some trade or other names: 4-methoxy-alpha-methylphenethylamine;
para-methoxyamphetamine; PMA);

 

(4-methoxy-1-naphthalenyl)(1-pentyl-1H-indol-3-yl)-methanone
(some trade or other names: JWH-081);

 

5-methoxy-3,4-methylenedioxyamphetamine
(some trade or other names: MMDA);

 

5-methoxy-N,
N-diisopropyltryptamine (some trade or other names: 5-meO-DIPT);

 

4-methyl-2,5-dimethoxyamphetamine
(some trade or other names: 4-methyl-2,5-dimethoxy-alpha-methylphenethylamine;
“DOM”; “STP”);

 

(4-methyl-1-naphthalenyl)(1-pentyl-1H-indol-3-yl)-methanone
(some trade or other names: JWH-122);

 

Methyl
2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (some
trade or other names: 5F-ADB; 5F-MDMB-PINACA);

 

Methyl
2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (some
trade or other names: 5F-MDMB-PICA);

 

Methylenedioxyamphetamine
(some trade or other names: MDA);

 

Methylenedioxymethamphetamine
(MDMA);

 

Methylenedioxy-N-ethylamphetamine
(commonly referred to as N-ethyl-alpha-methyl-3,4(methylenedioxy) phenethylamine,
N-ethyl MDA, MDE, MDEA);

 

MMB-FUBICA ester
(some trade or other names: Methyl
2-(1-(4-fluorobenzyl)-1H-indole-3-carboxamido)-3-methyl butanoate;
N-[[1-[(4-fluorophenyl)methyl]-1H-indol-3-yl]carbonyl]-L-valine, methyl ester);

 

1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole-7200
(some trade or other names: JWH-200);

 

N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide
(some trade or other names: FUB-AKB48; FUB-APINACA; AKB48 N-(4-fluorobenzyl);

 

N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide
(some trade or other names:
1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3-carboxamide; APINACA;
AKB48);

 

N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide
(trade or other names: ADB-CHMINACA; MAB-CHMINACA);

 

N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide
(trade or other name: ADB-PINACA);

 

N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide
(some trade or other names: AB-PINACA);

 

N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide
(trade or other name: AB-FUBINACA);

 

N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide
(trade or other name: AB-CHMINACA);

 

N-hydroxy-3,4-methylenedioxyamphetamine
(commonly referred to as N-hydroxy-alpha-methyl-3,4(methylenedioxy)
phenethylamine, N-hydroxy MDA);

 

2-(2-methoxyphenyl)-1-(1-pentylindol-3-yl)ethanone
(some trade or other names:
1-(1-pentyl-1H-indol-3-yl)-2-(2-methoxyphenyl)-ethanone; 1-pentyl-3-(2-methoxyphenylacetyl)indole;
JWH-250);

 

Nifoxipam (some
trade or other names:
5-(2-fluorophenyl)-1,3-dihydro-3-hydroxy-7-nitro-2H-1,4-benzodiazepin-2-one;
1,3-Dihydro-5-(2-fluorophenyl)-3-hydroxy-7-nitro-2H-1,4-benzodiazepin-2-one;
3-hydroxydesmethylflunitrazepam; DP 370);

 

Nitrazolam (some
trade or other names:
1-methyl-8-nitro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine);

 

Norflurazepam (some
trade or other names:
7-chloro-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one; nor-Flurazepam;
N-Desalkylflurazepam; Desalkylflurazepam; Ro 5-3367);

 

1-Pentyl-3-(2-chlorophenylacetyl)indole
(some trade or other names: JWH-203);

 

1-Pentyl-3-(4-cholor-1-naphthoyl)indole
(some trade or other names: JWH-398);

 

1-Pentyl-3-[(4-methoxy)-benzoyl]indole
(some trade or other names: SR-19; BTM-4; RCS-4);

 

1-Pentyl-3-(1-naphthoyl)indole-7118
(some trade or other names: JWH-018; AM678);

 

(1-pentylindol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone
(some trade or other names: UR-144);

 

1-pentyl-N-(tricyclo[3.3.1.1
3,7
]dec-1-yl-1H-indole-3
carboxamide (some trade or other names: APICA; JWH-018 adamantyl carboxamide;
2NE1; SDB-001);

 

1-pentyl-8-quinolinyl
ester-1H-indole-3-carboxylic acid (some trade or other names:
1-pentyl-1H-indole-3-carboxylic acid 8-quinolinyl ester; PB-22; QUPIC);

 

Phenazepam (some
trade or other names:
7-bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one;
7-bromo-5-(2-chlorophenyl)-1,2-dihydro-3H-1,4-benzodiazepin-2-one; BD 98;
Fenazepam; Elzepam; Phezipam; Phenorelaxan; Phenzitat);

 

Pyrazolam (some
trade or other names:
8-bromo-1-methyl-6-(2-pyridinyl)-4H-(1,2,4)triazolo(4,3-a)(1,4)benzodiazepine;
8-bromo-1-methyl-6-(pyridin-2-yl)-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine;
Pirazolam);

 

3,4,5-trimethoxyamphetamine;

 

Bufotenine (some
trade or other names: 3-(beta-dimethylaminoethyl)-5-hydroxyindole;
3-(2-dimethyl-aminoethyl)-5-indolol; N, N-dimethylserotonin; 5-hydroxy-N,
N-dimethyltryptamine; mappine);

 

Diethyltryptamine
(some trade or other names: DET; N,N-Diethyltryptamine);

 

Dimethyltryptamine
(some trade or other names: DMT; N,N-DMT; N,N-Dimethyltryptamine);

 

Fluorophenylpiperazine
(some trade or other names: FPP, pFPP, 2-fluorophenylpiperazine,
3-fluorophenylpiperazine, 4-fluorophenylpiperazine);

 

Gamma butyrolactone
(some trade or other names: GBL, Gamma Buty Lactone, 4-butyrolactone,
dihydro-2(3H)-furanone, tetrahydro-2-furanone, Gamma G, GH Gold);

 

Gamma hydroxy
butyric acid (some trade or other names: GHB);

 

Ibogaine (some
trade or other names: 7-ethyl-6, 6 beta, 7, 8, 9, 10, 12,
13-octahydro-2-methoxy-6, 9-methano-5H-pyrido (1',2':1,2) azepino (5,4-b)
indole;
Tabernanthe iboga
);

 

Lysergic acid
diethylamide;

 

Marijuana;

 

Mescaline;

 

Methoxyphenylpiperazine
(some trade or other names: MeOPP, pMPP, 4-MPP, 2-MeOPP, 3-MeOPP, 4-MeOPP);

 

Parahexyl (some
trade or other names: 3-Hexyl-1-hydroxy-7, 8, 9,
10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran; Synhexyl);

 

Peyote (meaning all
parts of the plant presently classified botanically as
Lophophora williamsii
Lemaire
, whether growing or not, the seeds thereof, any extract from any
part of such plant, and every compound, manufacture, salts, derivative,
mixture, or preparation of such plant, its seeds or extracts);

 

N-benzylpiperazine
(some trade or other names: BZP, 1-benzylpiperazine);

 

N-ethyl-3-piperidyl
benzilate;

 

N-methyl-3-piperidyl
benzilate;

 

Psilocybin;

 

Psilocin;

 

Salvinorin A (some
trade or other names: Divinorin A; Methyl
(2S,4aR,6aR,7R,9S,10aS,10bR)-9-(acetyloxy)-2-(furan-3-yl)-6a,10b-dimethyl-4,10-
dioxododecahydro-2H-benzo[f]isochromene-7-carboxylate);

 

Ethylamine analog
of phencyclidine (some trade or other names: N-ethyl-1-phenylcyclohexylamine;
(1-phenylcyclohexyl) ethylamine; N-(1-phenylcyclohexyl) ethylamine;
cyclohexamine; PCE);

 

Pyrrolidine analog
of phencyclidine (some trade or other names:
1-(1-phenylcyclohexyl)-pyrrolidine; PCPy; PHP);

 

1-(1-(2-thienyl)-cyclohexyl)-pyrrolidine
(some trade or other names: TCPy);

 

Thiophene analog of
phencyclidine (some trade or other names: 1-(1-(2-thienyl)-cyclohexyl)-piperidine;
2-thienyl analog of phencyclidine; TPCP; TCP); or

 

Trifluoromethylphenylpiperazine
(some trade or other names: 1-(3-trifluoromethylphenyl)piperazine;
3-trifluoromethylphenylpiperazine; TFMPP).

 

For the purposes of this subsection, "isomer" includes,
without limitation, the optical, position or geometric isomer.
Nev. Admin. Code 453.530(10) · Schedule III, ketamineOFFICIAL
Instrument
Schedule III, ketamine
Source
https://www.leg.state.nv.us/NAC/NAC-453.html
Retrieved
2026-10-31
Fingerprint
df44a61af02afaf6
10.  Ketamine, including its salts, isomers
and salts of isomers, is hereby enumerated on schedule III.
Show 4 more laws on file
NRS 453.043 (controlled substance analog); see also NAC 453.510(4) (Schedule I hallucinogens) · Controlled substance analog definedOFFICIAL
Instrument
Controlled substance analog defined
Source
https://www.leg.state.nv.us/NRS/NRS-453.html
Retrieved
2026-10-29
Fingerprint
2b0e9042d84a20c0
1.  “Controlled substance analog” means a
substance the chemical structure of which is substantially similar to the
chemical structure of a controlled substance placed in schedule I or II and:

      (a) Which has a stimulant, depressant or
hallucinogenic effect on the central nervous system substantially similar to
the stimulant, depressant or hallucinogenic effect on the central nervous
system of a controlled substance placed in schedule I or II pursuant to
NRS 453.166
 or
453.176
; or

      (b) With respect to a particular person, which he
or she represents or intends to have a stimulant, depressant or hallucinogenic
effect on the central nervous system substantially similar to the stimulant,
depressant or hallucinogenic effect on the central nervous system of a
controlled substance included in schedule I or II.

      2.  The term does not include:

      (a) A controlled substance;

      (b) A substance for which there is an approved
new drug application;

      (c) A substance with respect to which an
exemption is in effect for investigational use by a particular person under
Section 505 of the federal Food, Drug, and Cosmetic Act (21 U.S.C. § 355) to
the extent conduct with respect to the substance is permitted by the exemption;
or

      (d) Any substance to the extent not intended for
human consumption before an exemption takes effect with respect to the
substance.

      (Added to NRS by
1991,
1644
)
NRS 453.043; NRS 453.219 · Controlled substance analog defined; treatment as a substance in Schedule IOFFICIAL
Instrument
Controlled substance analog defined; treatment as a substance in Schedule I
Source
https://www.leg.state.nv.us/nrs/nrs-453.html
Retrieved
2026-10-29
Fingerprint
26c5bdda074aa93e
NRS 
453.043
  
“Controlled substance analog” defined.

      1.  “Controlled substance analog” means a
substance the chemical structure of which is substantially similar to the
chemical structure of a controlled substance placed in schedule I or II and:

      (a) Which has a stimulant, depressant or
hallucinogenic effect on the central nervous system substantially similar to
the stimulant, depressant or hallucinogenic effect on the central nervous
system of a controlled substance placed in schedule I or II pursuant to
NRS 453.166
 or
453.176
; or

      (b) With respect to a particular person, which he
or she represents or intends to have a stimulant, depressant or hallucinogenic
effect on the central nervous system substantially similar to the stimulant,
depressant or hallucinogenic effect on the central nervous system of a
controlled substance included in schedule I or II.

      2.  The term does not include:

      (a) A controlled substance;

      (b) A substance for which there is an approved
new drug application;

      (c) A substance with respect to which an
exemption is in effect for investigational use by a particular person under
Section 505 of the federal Food, Drug, and Cosmetic Act (21 U.S.C. § 355) to
the extent conduct with respect to the substance is permitted by the exemption;
or

      (d) Any substance to the extent not intended for
human consumption before an exemption takes effect with respect to the
substance.

      (Added to NRS by
1991,
1644
)

NRS 
453.219
  
Controlled substance analog: Treatment as substance in schedule
I; notice of prosecution; determination by Board.
  
A
controlled substance analog, to the extent intended for human consumption, must
be treated, for the purposes of
NRS 453.011

to
453.552
, inclusive, as a substance
included in schedule I. Within 30 days after the initiation of prosecution with
respect to a controlled substance analog by indictment or information, the
district attorney shall notify the Board of information relevant to scheduling
by extraordinary regulation as provided for in
NRS 453.2184
. If the Board finally
determines that the controlled substance analog should not be scheduled, no
prosecution relating to that substance as a controlled substance analog may be
commenced or continued.

      (Added to NRS by
1991,
1646
; A
2001,
1056
;
2003,
552
)
NRS 453.2182; NRS 453.219; NRS 453.043 · Board treatment of federally scheduled substances; controlled substance analog (treatment and definition)OFFICIAL
Instrument
Board treatment of federally scheduled substances; controlled substance analog (treatment and definition)
Source
https://www.leg.state.nv.us/NRS/NRS-453.html
Retrieved
2026-11-06
Fingerprint
181d6eace9b04684
If
a substance is designated, rescheduled or deleted as a controlled substance
pursuant to federal law, the Board shall similarly treat the substance pursuant
to the provisions of
NRS 453.011
 to
453.552
, inclusive, after the expiration of
60 days from publication in the Federal Register of a final order designating a
substance as a controlled substance or rescheduling or deleting a substance or
from the date of issuance of an order of temporary scheduling under Section 508
of the federal Dangerous Drug Diversion Control Act of 1984, 21 U.S.C. §
811(h), unless within the 60-day period, the Board or an interested party
objects to the treatment of the substance. If no objection is made, the Board
shall adopt, without making the determinations or findings required by
subsections 1 to 4, inclusive, of
NRS
453.146
 or
NRS 453.166
,
453.176
,
453.186
,

453.196
 or
453.206
, a final regulation treating the
substance. If an objection is made, the Board shall make a determination with
respect to the treatment of the substance as provided by subsections 1 to 4,
inclusive, of
NRS 453.146
. Upon receipt
of an objection to the treatment by the Board, the Board shall publish notice
of the receipt of the objection, and action by the Board is stayed until the
Board adopts a regulation as provided by subsection 4 of
NRS 453.146
.

A
controlled substance analog, to the extent intended for human consumption, must
be treated, for the purposes of
NRS 453.011

to
453.552
, inclusive, as a substance
included in schedule I. Within 30 days after the initiation of prosecution with
respect to a controlled substance analog by indictment or information, the
district attorney shall notify the Board of information relevant to scheduling
by extraordinary regulation as provided for in
NRS 453.2184
. If the Board finally
determines that the controlled substance analog should not be scheduled, no
prosecution relating to that substance as a controlled substance analog may be
commenced or continued.

1.  “Controlled substance analog” means a
substance the chemical structure of which is substantially similar to the
chemical structure of a controlled substance placed in schedule I or II and:

      (a) Which has a stimulant, depressant or
hallucinogenic effect on the central nervous system substantially similar to
the stimulant, depressant or hallucinogenic effect on the central nervous
system of a controlled substance placed in schedule I or II pursuant to
NRS 453.166
 or
453.176
; or

      (b) With respect to a particular person, which he
or she represents or intends to have a stimulant, depressant or hallucinogenic
effect on the central nervous system substantially similar to the stimulant,
depressant or hallucinogenic effect on the central nervous system of a
controlled substance included in schedule I or II.

      2.  The term does not include:

      (a) A controlled substance;

      (b) A substance for which there is an approved
new drug application;

      (c) A substance with respect to which an
exemption is in effect for investigational use by a particular person under
Section 505 of the federal Food, Drug, and Cosmetic Act (21 U.S.C. § 355) to
the extent conduct with respect to the substance is permitted by the exemption;
or

      (d) Any substance to the extent not intended for
human consumption before an exemption takes effect with respect to the
substance.
NRS 454.346 · Use or possession with intent to use drug, chemical, poison or organic solvent to induce euphoria or hallucinations unlawful; exceptionOFFICIAL
Instrument
Use or possession with intent to use drug, chemical, poison or organic solvent to induce euphoria or hallucinations unlawful; exception
Source
https://www.leg.state.nv.us/NRS/NRS-454.html#NRS454Sec346
Retrieved
2026-10-31
Fingerprint
2895e8b60aedcc9c
Use or possession with intent to use drug, chemical, poison or
organic solvent to induce euphoria or hallucinations unlawful; exception.

      1.  Any person who inhales, ingests,
applies or otherwise uses or possesses with the intent to inhale, ingest, apply
or otherwise use any drug, chemical, poison or organic solvent, or any compound
or combination of any drug, chemical, poison or organic solvent, in any manner
contrary to the directions for use, cautions or warnings appearing on the label
thereof, in order to create or induce a condition of intoxication, euphoria,
hallucination or elation, or to change, distort or disturb his or her eyesight,
thinking processes, balance or coordination or to affect his or her central
nervous system is guilty of a misdemeanor.

      2.  The provisions of this section do not
apply to a person who uses or intends to use any drug, chemical, poison or
organic solvent for medicinal purposes under the supervision of a physician,
when the drug, chemical, poison or organic solvent is used or intended for use
in keeping with the directions for use as given by the physician.

      (Added to NRS by
1973,
75
; A
1983,
242
)

Phenibut in neighboring states

Phenibut in 45 other states

Closest to Phenibut in Nevada

Same framework in Nevada

23 other compounds in Nevada

Cite this page

Compound Analytics. "Is Phenibut Legal in Nevada? Updated Nov 2026." Compound Laws, https://compoundlaws.com/compounds/phenibut/nevada/. Accessed November 13, 2026.

Compound Laws, published by Compound Analytics, reports the record: statutes verbatim, official citations, enforcement facts and verification dates. Nothing here is legal advice and nothing here describes how to get around a law. A jurisdiction with no verified row is reported as not yet verified, never as legal. Found an error? Corrections policy.

About · Methodology · Glossary · Changes · RSS · Data licensing · llms.txt · Sitemap